Frankincense and Myrrh Benefits: What the Research Shows About These Ancient Botanicals

Few plant-based substances carry as much historical weight as frankincense and myrrh. Used for thousands of years in traditional medicine systems across the Middle East, Africa, and Asia, these two tree resins have attracted growing scientific interest for their potential role in supporting inflammation response, joint health, and more. Here's what the research generally shows — and why individual factors matter enormously when thinking about either one.

What Are Frankincense and Myrrh?

Frankincense is a resin harvested from trees in the Boswellia genus, primarily Boswellia serrata and Boswellia sacra. The resin is extracted by making cuts in the tree bark and allowing the sap to harden. Its active compounds — particularly boswellic acids, including AKBA (acetyl-11-keto-β-boswellic acid) — are the focus of most modern research.

Myrrh comes from trees in the Commiphora genus, most notably Commiphora myrrha. Its bioactive compounds include terpenoids, sesquiterpenes, and furanosesquiterpenes, with much of the research attention going to a compound called guggulsterone, which also appears in related resin products.

Both resins are available as raw resin, essential oils, standardized supplements, and topical preparations. The form significantly affects what compounds are absorbed and how.

What Does the Research Say About Frankincense? 🔬

The most consistently studied area for frankincense is inflammation modulation. Boswellic acids appear to inhibit a specific enzyme called 5-lipoxygenase (5-LOX), which plays a role in producing inflammatory compounds called leukotrienes. Unlike many common anti-inflammatory drugs that work through the COX pathway, boswellic acids target a different pathway, which has drawn interest from researchers studying joint and airway health.

Joint and mobility research has produced some promising results. Several clinical trials — including randomized controlled trials, which carry stronger evidentiary weight than observational studies — have examined Boswellia serrata extracts in people with knee osteoarthritis. Some trials reported improvements in pain and physical function scores compared to placebo, though effect sizes varied and study populations were small. Researchers continue to investigate optimal dosing, extract standardization, and long-term safety.

Gut health is another area of emerging research. A limited number of trials have explored boswellic acid extracts in conditions involving intestinal inflammation, with early findings suggesting possible benefit — though this research is still considered preliminary and shouldn't be interpreted as evidence that frankincense treats any gastrointestinal condition.

Frankincense essential oil is frequently studied for antimicrobial properties in laboratory settings. Lab results, however, don't automatically translate to clinical benefit in humans — a distinction worth keeping in mind when reading about this research.

What Does the Research Say About Myrrh?

Myrrh research is somewhat less developed than frankincense's, but several areas have received scientific attention.

Antimicrobial activity is among the most studied properties of myrrh extracts, primarily in laboratory and animal models. Some studies have examined myrrh's potential against certain bacterial and fungal strains in controlled settings. These findings are interesting but require significant further research before drawing conclusions about human health applications.

Wound healing and oral health have also been explored, with myrrh traditionally used in mouth rinses and topical preparations. Some small studies suggest myrrh-containing rinses may have a role in oral hygiene support, though the evidence base is limited.

Myrrh has also been studied alongside other botanicals — including alongside frankincense — for anti-inflammatory activity. Some researchers believe the two compounds may work synergistically, though robust human clinical trial data on the combination specifically is sparse.

How Frankincense and Myrrh Compare Across Key Research Areas

Variables That Shape Individual Responses 🌿

Even where research findings are positive, how someone responds to either resin depends on several factors:

• Form and standardization: Supplements vary widely in the concentration of active compounds. A product standardized for AKBA content is chemically distinct from raw resin or an essential oil.
• Bioavailability: Boswellic acids are fat-soluble, meaning absorption may increase when taken with food containing fat. Myrrh compounds also vary in absorption depending on preparation.
• Existing health conditions: People with certain liver conditions, inflammatory bowel conditions, or clotting disorders may respond differently to these compounds.
• Medications: Both frankincense and myrrh may interact with medications that affect blood clotting, blood sugar regulation, or liver enzymes. Drug interaction data is still developing for both.
• Age and metabolic factors: Older adults and individuals with slower metabolism may process plant compounds differently than younger, healthy adults studied in trials.
• Dosage duration: Most trials have run for eight to twelve weeks. Longer-term effects — positive or negative — are less well understood.

Who Has Been Studied — and Who Hasn't

Much frankincense research has been conducted in adults with specific joint or digestive conditions. Myrrh research skews heavily toward laboratory and animal models. This means findings may not generalize to healthy adults, children, pregnant individuals, or people with complex health profiles.

The gap between what research populations show and what any particular person might experience is real — and it's shaped entirely by that person's own health status, existing diet, medications, and circumstances.